Chief executive, Molecular Designs
Appears in 1 story
Last updated Nov 15, 2026
Leads the company through its first commercial diagnostic launch
Molecular Designs has sold molecular reagents labeled for research use only. On Nov. 13, the Food and Drug Administration cleared its first diagnostic: one run that detects and separates influenza A, influenza B and respiratory syncytial virus from a single anterior nasal swab.
Updated 3 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?